Add BrightSurf on Google Email

Dietary shift after migration increases cardiovascular risk by altering the composition of an individual's gut microbiome

A study found that migrants experience a 'clear change' in their gut microbiome composition after migration, leading to increased rates of cardiovascular disease. The Amsterdam UMC-led research showed that specific groups of microbes disappear or emerge along the migration axis.

SourceAmsterdam University Medical Center·JournalGut Microbes·TypeObservational study·DateApr 7, 2025

Calorie-free sweeteners can disrupt the brain’s appetite signals

A study found that consuming sucralose alters brain activity related to hunger and increases appetite, especially in people with obesity. The sugar substitute changes how the hypothalamus communicates with other brain regions, including those involved in motivation, potentially leading to cravings and eating behavior changes.

SourceKeck School of Medicine of USC·JournalNature Metabolism·TypeExperimental study·DateMar 26, 2025

Most older adults say Medicare and other insurance should cover obesity drugs, and many show interest in using them

A large majority of older Americans believe health insurance – including Medicare – should cover anti-obesity medications. Nearly 37% of respondents met the criteria for overweight and 36% for obesity. Medicare currently covers a drug used for weight management but only in people with diabetes or a history of heart attack or stroke.

SourceMichigan Medicine - University of Michigan·JournalJAMA Network Open·TypeSurvey·DateMar 26, 2025

Milk as Medicine: New Study Shows Breast Milk Transforms Challenges into Triumphs

A recent study published in The Journal of the American Medical Association found that breast milk from mothers with gestational diabetes has a unique composition that benefits their infant children. Babies of mothers with gestational diabetes experience faster linear growth, lower fat percentages, and reduced weight gain.

SourceUniversity of Oklahoma·JournalJournal of the American Medical Association·TypeRandomized controlled/clinical trial·DateMar 25, 2025

HKUMed discovers a mechanism of C-reactive protein that exacerbates inflammation in diabetic kidney disease, offering new treatment directions for patients

A study published by HKUMed has found that C-reactive protein (CRP) can worsen inflammation in diabetic kidney disease through the Smad3-NLRP3 inflammasome-dependent mechanism. The research suggests that targeting CRP or the Smad3-NLRP3 pathway may provide new treatment options for patients with DKD.

SourceThe University of Hong Kong·JournalMolecular Therapy·TypeExperimental study·DateMar 17, 2025

ENDO 2025 opens media registration

Media professionals can register for ENDO 2025 to discuss groundbreaking research on obesity, diabetes, and more with world-renowned experts. The event features nearly 2,500 abstracts and over 200 sessions, offering a premier global conference in endocrinology research and clinical care.

Updated chronic kidney disease management guidelines recommend SGLT2 inhibitors regardless of diabetes or kidney disease type

The American College of Physicians updates its guidelines recommending SGLT2 inhibitors for chronic kidney disease (CKD) management, regardless of diabetes type. The new guidelines emphasize the importance of tailored care and suggest individualized risk-based approaches to predict kidney failure.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateMar 10, 2025

Diabetes drug could help cancer patients make better recovery

A new study published in the European Journal of Preventive Cardiology found that a type of diabetes medication called SGLT2 inhibitors can significantly lower the risk of heart failure and hospital visits related to heart failure in cancer patients. The benefits were particularly promising for breast cancer patients receiving anthracy...

SourceUniversity of East Anglia·JournalEuropean Journal of Preventive Cardiology·TypeMeta-analysis·DateMar 5, 2025

New drug shows promise in treating liver disease caused by metabolic dysfunction, cancer

A new drug candidate has been developed to target and eliminate senescent cells in the liver, reducing fat buildup and preventing liver damage. The study demonstrates a safer and more effective approach to treating metabolic dysfunction-associated steatotic liver disease (MASLD) and potentially inhibiting liver cancer development.

We feed gut microbes sugar, they make a compound we need

Researchers at Kobe University discovered that gut microbes convert glucose into short-chain fatty acids when fed sugar, highlighting a new symbiotic relationship. This finding could lead to the development of novel therapeutics for regulating gut microbiota and their metabolites.

SourceKobe University·JournalCommunications Medicine·TypeExperimental study·DateMar 3, 2025

Prevalence and control of diabetes among US adults

The study found that the prevalence of adults with diabetes did not significantly change between 2013 and 2023. However, glycemic control among those with diagnosed disease worsened, particularly among young adults. This trend is concerning due to its potential impact on lifetime risk of cardiovascular events.

SourceJAMA Network·JournalJAMA·DateFeb 27, 2025

Causal relationship between type II diabetes mellitus, metformin, insulin, gliclazide, and esophageal cancer—insights from two-sample Mendelian randomization study and meta-analysis

A genetic predisposition to type II diabetes mellitus is associated with a reduced risk of esophageal cancer. Metformin use has been shown to decrease the prevalence of esophageal cancer, while insulin and gliclazide have no significant association.

SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeObservational study·DateFeb 25, 2025

Guidelines needed for interpreting continuous glucose monitoring reports in those without diabetes

A new study found high discordance among clinical experts on interpreting CGM reports from individuals without diabetes, highlighting the need for more research and guidelines. Experts recommend follow-up and specific reasoning for their decisions, despite having extensive CGM experience.

SourceBoston University School of Medicine·JournalJournal of Diabetes Science and Technology·TypeSurvey·DateFeb 18, 2025

Brain network disorders review uncovers the link between metabolic disorders and Alzheimer's disease

Researchers explore the connection between Alzheimer's and metabolic syndrome, finding links between insulin regulation, high blood pressure, and obesity. The study suggests that maintaining healthy blood fat levels may be crucial for brain health, paving way for potential therapeutic developments.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateFeb 18, 2025

Researchers uncover surprising link to stroke risk

A new study from the University of Texas at Arlington found that Americans aged 65 and older who experienced parental divorce as children were more likely to suffer a stroke compared to their peers. The study analyzed data from over 13,000 older Americans and found that about 14% had experienced parental divorce during childhood.

SourceUniversity of Texas at Arlington·JournalPLOS One·TypeData/statistical analysis·DateFeb 18, 2025

Inadequate postpartum screening for hypertension and diabetes a ‘missed opportunity’ for women, study suggests

A new study published in Circulation suggests that less than one in five patients are tested for cardiovascular risk factors following pregnancy-related hypertension or diabetes. This leaves women without adequate screening for high blood pressure, lipids, and sugars, increasing their risk of future stroke or heart disease.

SourceInstitute for Clinical Evaluative Sciences·JournalCirculation·TypeObservational study·DateFeb 17, 2025

A new switch for the cell therapies of the future

Researchers have developed a new gene switch that uses nitroglycerine to trigger the production of insulin and regulate blood sugar levels in people with diabetes. This switch is made exclusively of human constituents, eliminating the risk of false triggering or immune reactions.

SourceETH Zurich·JournalNature Biomedical Engineering·DateFeb 14, 2025

Mouse study finds impaired cell development: Intermittent fasting could be unsafe for teenagers

A recent study reveals that intermittent fasting can impair beta-cell function and maturation in young mice, potentially leading to diabetes. Researchers found that adolescent mice showed a decline in insulin production after prolonged fasting, with defective beta cells resembling those of type 1 diabetes patients.

SourceTechnical University of Munich (TUM)·JournalCell Reports·TypeExperimental study·DateFeb 14, 2025

New study finds lower cardiovascular risk in Type 1 diabetes compared to Type 2 diabetes

A new study published in JSCAI reveals a lower risk of cardiovascular events for people with Type 1 diabetes, compared to those with Type 2 diabetes. The research highlights the importance of distinguishing between the two types of diabetes and developing targeted treatment strategies.

SourceSociety for Cardiovascular Angiography and Interventions·JournalJournal of the Society for Cardiovascular Angiography & Interventions·DateFeb 12, 2025

New details about insulin production deciphered

Scientists at the University of Würzburg have discovered that fruit fly nerve cells release insulin into the haemolymph when ingesting sugar, not when it's injected directly. This phenomenon is similar to the incretin effect in humans, suggesting complex mechanisms controlling insulin secretion.

SourceUniversity of Würzburg·JournaleLife·TypeExperimental study·DateFeb 5, 2025

Diabetes-linked amputations surge in Oklahoma amid national decline, OU study finds

A new University of Oklahoma study found that diabetes-linked amputations are rising in Oklahoma, with the statewide rate nearly doubling between 2008 and 2019. The study analyzed over 1.3 million anonymized discharge records and found that rates were highest among males, American Indians, and those with poor health insurance coverage.

SourceUniversity of Oklahoma·JournalJournal of Vascular Surgery·TypeObservational study·DateFeb 4, 2025